Bipolar II disorder
Information
- Disease name
- Bipolar II disorder
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03641300 | Active, not recruiting | N/A | Efficacy of Convulsive Therapies for Bipolar Depression | September 21, 2018 | August 30, 2024 |
| NCT03484494 | Active, not recruiting | N/A | Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression | May 29, 2018 | August 30, 2023 |
| NCT05249309 | Active, not recruiting | Naturalistic Study of Ketamine in the Treatment of Depression | May 1, 2021 | December 15, 2023 | |
| NCT05658510 | Active, not recruiting | Phase 3 | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) | November 21, 2022 | March 30, 2025 |
| NCT01075295 | Completed | N/A | Prevention of Weight Gain in Early Psychoses | February 2010 | December 2012 |
| NCT01588457 | Completed | Phase 4 | Sequential Multiple Assignment Treatment for Bipolar Disorder | June 2011 | December 2016 |
| NCT01731119 | Completed | Phase 2 | Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents | December 2012 | August 2014 |
| NCT00186043 | Completed | Phase 4 | Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II | August 2008 | August 2011 |
| NCT02593643 | Completed | Early Phase 1 | Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression. | January 2016 | April 2017 |
| NCT03156504 | Completed | Phase 4 | The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. | June 1, 2017 | March 12, 2020 |
| NCT03334721 | Completed | Phase 2 | Gabapentin for Bipolar & Cannabis Use Disorders | October 1, 2017 | July 1, 2019 |
| NCT03810703 | Completed | Phase 1 | Differential Responses to Drugs and Sweet Tastes | February 9, 2017 | August 9, 2018 |
| NCT03822416 | Completed | Phase 2 | Treating Smokers With Mental Illness | March 1, 2019 | May 4, 2020 |
| NCT05340504 | Completed | Phase 2 | Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder | May 13, 2022 | June 21, 2023 |
| NCT00237666 | Completed | Phase 4 | Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression | February 2005 | February 2008 |
| NCT00411463 | Completed | Phase 2/Phase 3 | Psychotherapy for Bipolar II Depression, Pilot Study, Phase II | December 2006 | September 2010 |
| NCT00761761 | Completed | Phase 3 | Sensoril(Ashwaganhda)for Bipolar Disorder | October 2008 | March 2011 |
| NCT05705063 | Not yet recruiting | N/A | Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness | January 30, 2023 | December 30, 2024 |
| NCT06184581 | Recruiting | Phase 4 | Lithium Versus Lamotrigine in Bipolar Disorder, Type II | May 8, 2024 | December 1, 2027 |
| NCT05004896 | Recruiting | Phase 2 | Ketamine for Treatment-Resistant Bipolar Disorder | July 4, 2022 | December 31, 2025 |
| NCT05064319 | Recruiting | Phase 2 | Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders | February 24, 2022 | June 30, 2026 |
| NCT05065294 | Recruiting | Phase 2 | Psilocybin Therapy for Depression in Bipolar II Disorder | January 28, 2022 | January 2024 |
| NCT05339074 | Recruiting | Phase 2 | Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression | August 11, 2022 | February 28, 2026 |
| NCT05340686 | Recruiting | N/A | Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression | October 26, 2022 | April 20, 2027 |
| NCT05400785 | Recruiting | N/A | Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning | May 27, 2022 | October 31, 2023 |
| NCT05427123 | Recruiting | Children's Bipolar Network Treatment Trial I | July 1, 2022 | July 1, 2026 | |
| NCT05839509 | Recruiting | Phase 2 | Phase 2 Clinical Trial of GH001 in Bipolar II Disorder | April 6, 2023 | December 2023 |
| NCT06129500 | Recruiting | N/A | CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB | August 17, 2023 | June 24, 2024 |
| NCT02491307 | Terminated | N/A | Ginger.io Behavioral Health Study | July 2015 | October 2015 |
| NCT04561622 | Unknown status | Emotional Proactive Processing in Bipolar Disorder | October 1, 2020 | October 1, 2022 | |
| NCT04211428 | Unknown status | A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder | March 2, 2020 | July 2023 | |
| NCT04035798 | Unknown status | Phase 2/Phase 3 | add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients | August 1, 2019 | July 31, 2022 |
| NCT03603561 | Unknown status | N/A | Continuous Theta Burst Stimulation as an add-on Treatment for Bipolar Depression | August 1, 2018 | July 2020 |
| NCT05420792 | Unknown status | N/A | The Effect of Interpersonal Relationships and Social Rhythm Therapy Individuals With Bipolar Disorder | August 1, 2021 | October 1, 2022 |